Premature ventricular complexes and development of heart failure in a community-based population.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
01 2022
Historique:
received: 09 04 2021
accepted: 09 08 2021
pubmed: 9 9 2021
medline: 30 4 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

A higher premature ventricular complex (PVC) frequency is associated with incident congestive heart failure (CHF) and death. While certain PVC characteristics may contribute to that risk, the current literature stems from patients in medical settings and is therefore prone to referral bias. This study aims to identify PVC characteristics associated with incident CHF in a community-based setting. The Cardiovascular Health Study is a cohort of community-dwelling individuals who underwent prospective evaluation and follow-up. We analysed 24-hour Holter data to assess PVC characteristics and used multivariable logistic and Cox proportional hazards models to identify predictors of a left ventricular ejection fraction (LVEF) decline and incident CHF, respectively. Of 871 analysed participants, 316 participants exhibited at least 10 PVCs during the 24-hour recording. For participants with PVCs, the average age was 72±5 years, 41% were women and 93% were white. Over a median follow-up of 11 years, 34% developed CHF. After adjusting for demographics, cardiovascular comorbidities, antiarrhythmic drug use and PVC frequency, a greater heterogeneity of the PVC coupling interval was associated with an increased risk of LVEF decline and incident CHF. Of note, neither PVC duration nor coupling interval duration exhibited a statistically significant relationship with either outcome. In this first community-based study to identify Holter-based features of PVCs that are associated with LVEF reduction and incident CHF, the fact that coupling interval heterogeneity was an independent risk factor suggests that the mechanism of PVC generation may influence the risk of heart failure.

Identifiants

pubmed: 34493549
pii: heartjnl-2021-319473
doi: 10.1136/heartjnl-2021-319473
pmc: PMC8702448
mid: NIHMS1735446
doi:

Substances chimiques

Anti-Arrhythmia Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-110

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201200036C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268200800007C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL080295
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL130114
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Am Soc Echocardiogr. 1992 Jan-Feb;5(1):63-72
pubmed: 1739473
Heart Rhythm. 2014 Feb;11(2):299-306
pubmed: 24184787
Circulation. 2016 Jan 12;133(2):156-64
pubmed: 26538580
Ann Thorac Surg. 2006 Aug;82(2):494-500; discussion 500-1
pubmed: 16863752
Ann Epidemiol. 1995 Jul;5(4):278-85
pubmed: 8520709
Heart. 2019 Sep;105(18):1408-1413
pubmed: 31142596
J Am Coll Cardiol. 2010 Nov 16;56(21):1712-9
pubmed: 21070922
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
Europace. 2007 Dec;9(12):1203-8
pubmed: 17965012
J Am Coll Cardiol. 2005 Apr 19;45(8):1259-65
pubmed: 15837259
Circulation. 2020 Apr 28;141(17):1404-1418
pubmed: 32339046
JACC Heart Fail. 2015 Jul;3(7):520-528
pubmed: 26160366
Circulation. 1995 Mar 15;91(6):1739-48
pubmed: 7882482
J Clin Epidemiol. 1992 Jun;45(6):683-92
pubmed: 1607909
Circulation. 2018 Sep 25;138(13):e210-e271
pubmed: 29084733
Ann Epidemiol. 1991 Feb;1(3):263-76
pubmed: 1669507
Jpn Circ J. 1993 Aug;57(8):781-8
pubmed: 7689116
J Am Coll Cardiol. 2015 Jul 14;66(2):101-9
pubmed: 26160626
Circ Heart Fail. 2012 Jul 1;5(4):422-9
pubmed: 22589298
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2870-2882
pubmed: 30522650
Ann Noninvasive Electrocardiol. 2013 Mar;18(2):118-25
pubmed: 23530481
Eur Heart J. 1992 Sep;13(9):1290-5
pubmed: 1396842
Circ Arrhythm Electrophysiol. 2017 Apr;10(4):
pubmed: 28408652
Heart. 2015 Jan;101(1):58-64
pubmed: 25381326
Ann Noninvasive Electrocardiol. 2016 Jan;21(1):41-8
pubmed: 25683593
J Cardiovasc Electrophysiol. 2011 Jul;22(7):791-8
pubmed: 21332870
J Cardiovasc Electrophysiol. 2014 Jul;25(7):756-62
pubmed: 24612052
Circ Heart Fail. 2012 Nov;5(6):786-93
pubmed: 23014130
J Interv Card Electrophysiol. 2018 Jan;51(1):25-33
pubmed: 29305677
Heart. 2009 Aug;95(15):1230-7
pubmed: 19429571

Auteurs

Worawan B Limpitikul (WB)

Medicine, University of California San Francisco, San Francisco, California, USA.

Thomas A Dewland (TA)

Division of Cardiology, Electrophysiology Section, University of California San Francisco, San Francisco, California, USA.

Eric Vittinghoff (E)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.

Elsayed Soliman (E)

Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Gregory Nah (G)

Division of Cardiology, Electrophysiology Section, University of California San Francisco, San Francisco, California, USA.

Christina Fang (C)

Division of Cardiology, Electrophysiology Section, University of California San Francisco, San Francisco, California, USA.

David S Siscovick (DS)

New York Academy of Medicine, New York, New York, USA.

Bruce M Psaty (BM)

Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, Washington, USA.

Nona Sotoodehnia (N)

Division of Cardiology, University of Washington, Seattle, Washington, USA.

Susan Heckbert (S)

Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, Washington, USA.

Phyllis K Stein (PK)

Cardiovascular Division, Washington University School of Medicine in Saint Louis, St Louis, Missouri, USA.

John Gottdiener (J)

Cardiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Xiao Hu (X)

Duke University School of Nursing, Durham, North Carolina, USA.

Ralf Hempfling (R)

Vivonetics, Newport Coast, California, USA.

Gregory M Marcus (GM)

Division of Cardiology, Electrophysiology Section, University of California San Francisco, San Francisco, California, USA Greg.Marcus@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH